From: Optimal therapeutic conditions for the neural stem cell-based management of ischemic stroke: a systematic review and network meta-analysis based on animal studies
Acute
 6.84 (-14.76, 28.82)
Subacute
 11.81 (-8.55, 31.47)
4.74 (-20.89, 30.02)
Chronic
 -11.16 (-22.46, -0.18)
-18.17 (-37.57, -1.35)
-22.87 (-40.39, -5.37)
Placebo